Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clindamycin vs Dapsone in Moderate Acne Vulgaris
NCT05926869Phase 2Completed
- Sponsor
- Jinnah Postgraduate Medical Centre
- Start
- Aug 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dapsone in acne vulgaris, sponsored by Jinnah Postgraduate Medical Centre. Started Aug 2022; status: completed.
02
Drugs
dapsone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT05926869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05926869.